Table 4.
Variable | Estimate | P value | OR |
Cardiac biomarkers | |||
NT-proBNP >125 pg/mL | 1.674 | 0.040* | 5.335 |
hs-TnI >37 ng/L | 0.587 | 0.625 | 1.798 |
CMR parameters | |||
LGE | −1.234 | 0.273 | 0.290 |
T1 native | −0.007 | 0.171 | 0.993 |
ECV % (>29) | 1.469 | 0.073 | 4.347 |
MPR % | 0.029 | 0.947 | 1.029 |
LVEDV/BSA | −0.041 | 0.475 | 0.959 |
LVESV/BSA | 0.155 | 0.230 | 1.167 |
LVEF | 0.185 | 0.222 | 1.203 |
LV mass/BSA | 0.049 | 0.298 | 1.050 |
*p<0.05.
BSA, body surface area; CMR, cardiovascular magnetic resonance; ECV, extracellular-volume fraction; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; hs-TnI, high-sensitivity troponin I; LGE, late gadolinium enhancement; LV, left ventricular; MPR, myocardial perfusion reserve; NT-proBNP, N-terminal pro-brain natriuretic peptide.;